LAWRENCE H YOUNG, MD
Osteopathic Medicine in New Haven, CT

License number
Connecticut 023761
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
789 Howard Ave Dana Building FL 3RD, New Haven, CT 06519
Phone
(203) 785-4629
(203) 785-3588 (Fax)

Organization information

See more information about LAWRENCE H YOUNG at bizstanding.com

Lawrence H Young MD

300 George St, New Haven, CT 06511

Categories:
Psychiatry Physicians
Phone:
(203) 688-4242 (Phone)


Lawrence H Young

333 Cedar St, New Haven, CT 06510

Status:
Inactive
Industry:
Medical Doctor's Office

Professional information

See more information about LAWRENCE H YOUNG at trustoria.com
Lawrence H Young Photo 1
Dr. Lawrence H Young, New Haven CT - MD (Doctor of Medicine)

Dr. Lawrence H Young, New Haven CT - MD (Doctor of Medicine)

Specialties:
Cardiology
Address:
Yale Cardiology
789 Howard Ave, New Haven 06519
(203) 785-4114 (Phone)
Procedures:
Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac Myocardial Perfusion Imaging, Chest CT (incl. Heart and Lungs), Coronary Angioplasty, Atherectomy and Stent
Conditions:
Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Ectasia, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Endocarditis, Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypertensive Heart Disease, Hypotension, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Pulmonary Valve Disease, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1985, Internal Medicine, 1983
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Yale Cardiology
789 Howard Ave, New Haven 06519
Yale - New Haven Hospital
20 York St, New Haven 06510
Education:
Medical School
Yale University School Of Medicine
Graduated: 1980
Yale New Haven Hospital
Graduated: 1981
Graduated: 1983
Graduated: 1986


Lawrence Young Photo 2
Lawrence Young, New Haven CT

Lawrence Young, New Haven CT

Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
Yale Physicians Practice
800 Howard Ave, New Haven, CT 06519
Education:
Yale University (1980)


Lawrence Young Photo 3
Compositions And Methods For Diagnosing And Treating Diseases And Disorders Associated With D-Dt

Compositions And Methods For Diagnosing And Treating Diseases And Disorders Associated With D-Dt

US Patent:
2014003, Jan 30, 2014
Filed:
Nov 23, 2011
Appl. No.:
13/989182
Inventors:
Richard J. Bucala - Cos Cob CT, US
Lawrence H. Young - Woodbridge CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 39/395, A61K 38/02, G01N 33/68, A61K 31/713
US Classification:
4241351, 5303871, 5303892, 5303881, 5303873, 536 245, 514 44 A, 4241721, 4241521, 4241331, 530300, 514 165, 435 792
Abstract:
The present invention relates to the discovery that altered levels of D-DT (also known as MIF-2) are associated with disorders and diseases. Thus, the present invention relates to compositions and methods useful of the assessment, diagnosis, characterization, prevention and treatment of disorders and diseases associated with an elevated level of D-DT. The present invention also relates to compositions and methods useful of the assessment, diagnosis, characterization, prevention and treatment of disorders and diseases associated with a reduced level of D-DT.


Lawrence Young Photo 4
Use Of Mif And Mif Pathway Agonists

Use Of Mif And Mif Pathway Agonists

US Patent:
2013020, Aug 15, 2013
Filed:
Jan 28, 2013
Appl. No.:
13/751887
Inventors:
Yale University - , US
Lawrence H. Young - Woodbridge CT, US
Assignee:
Yale University - New Haven CT
International Classification:
A61K 39/395, A61K 31/7088, C12Q 1/68
US Classification:
4241361, 435 611, 514 44 R
Abstract:
The present invention relates to novel methods and compositions for increasing AMPK activity and glucose uptake comprising administering a macrophage migration inhibitory factor (MIF) pathway agonist in a subject in need thereof. The invention also relates to methods for selecting a subject for treatment with an agonist of MIF, identifying a subject at risk for developing a condition in which increased AMPK activity is desirable, and for predicting whether a subject is susceptible to a condition in which increased AMPK activity is desirable.